Anti-PD1 Antibody
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| TACE Combined With Lenvatinib and PD-1 Inhibitor for Ruptured Hepatocellular Carcinoma (NCT06740370) | Sun Yat-sen University | 2024-12-13 |
| Ablation of Oligometastasis Combined With Lenvatinib and PD-1 Inhibitor for Advanced Hepatocellular Carcinoma (NCT06550921) | Sun Yat-sen University | 2024-08-01 |
| Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma (NCT04627012) | Sun Yat-sen University | 2018-01-01 |
Track Anti-PD1 Antibody automatically
Every clearance here is in the API, with alerts when new ones post.